HC Wainwright Forecasts Stronger Earnings for Urogen Pharma
Urogen Pharma (NASDAQ:URGN – Free Report) – Analysts at HC Wainwright lifted their Q3 2026 earnings per share estimates for shares of Urogen Pharma in a note issued to investors on Thursday, August 6th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings of ($0.07) per share for the quarter, up […]
11 Aug 05:12 · The Markets Daily